Understanding the impact of teledermatology on no-show rates and health care accessibility: A retrospective chart review - 15/02/21
Funding: Supported by Harvard Catalyst, The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR002541) and financial contributions from Harvard University and its affiliated academic health care centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. |
|
Conflicts of interest: None declared. |
|
IRB status: The institutional review board of the University of Massachusetts designated this study exempt from institutional review as a quality improvement project. |
|
Reprints not available from the authors. |
Vol 84 - N° 3
P. 769-771 - mars 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?